Keval Y. Raval
Anand, GJ 388421, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrated computational and in vitro investigation to explore the preliminary anti-proliferative and anti-mitotic potential of γ-oryzanol against breast cancer.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 16, 2026
Comprehensive computer analysis of an intratumoral viable biological agent as a systemic multi-mechanistic therapeutic strategy for pancreatic cancer treatment.
Journal: In silico pharmacology
Published: February 23, 2026
In-vitro and In-silico Evaluation of Supercritical Extract of Acacia Auriculiformis against Breast Cancer.
Journal: Cell biochemistry and biophysics
Published: September 10, 2025
Comprehensive evaluation of Lactobacillus strains and Bacillus coagulans against Bisphenol-A induced neuronal and cardiac toxicities.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 11, 2025
Gmelinol ameliorates type 2 diabetes and multi-organ complications in streptozotocin-nicotinamide-induced diabetic rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 28, 2025
Anti-Diabetic and Insulinotropic Effects of p-Anisic Acid in High-Fat Diet and Streptozotocin Induced Type-2 Diabetic Rats.
Journal: Chemistry & biodiversity
Published: June 28, 2024
Pre-clinical Evaluation of Karanjin Against DMBA-Induced Breast Cancer in Female Sprague-Dawley Rats Through Modulation of SMAR1 and CDP/CUx genes.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 11, 2024
A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats.
Journal: Journal of diabetes and metabolic disorders
Published: September 12, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026